Shinva Medical Instrument Co Ltd
Shinva Medical Instrument Co.,Ltd. provides medical devices, pharmaceutical equipment, medical services, and medical trade in the People's Republic of China. The company offers medical devices, including infection control instruments such as washing disinfection, sterilization, and consumables; radiotherapy equipment; and surgical instruments and biomedical consumables comprising standard, neuro,… Read more
Shinva Medical Instrument Co Ltd (600587) - Net Assets
Latest net assets as of September 2025: CN¥8.16 Billion CNY
Based on the latest financial reports, Shinva Medical Instrument Co Ltd (600587) has net assets worth CN¥8.16 Billion CNY as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥15.08 Billion) and total liabilities (CN¥6.91 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥8.16 Billion |
| % of Total Assets | 54.15% |
| Annual Growth Rate | 21.78% |
| 5-Year Change | 64.32% |
| 10-Year Change | 101.21% |
| Growth Volatility | 46.33 |
Shinva Medical Instrument Co Ltd - Net Assets Trend (1999–2024)
This chart illustrates how Shinva Medical Instrument Co Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Shinva Medical Instrument Co Ltd (1999–2024)
The table below shows the annual net assets of Shinva Medical Instrument Co Ltd from 1999 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥7.98 Billion | +3.40% |
| 2023-12-31 | CN¥7.72 Billion | +33.35% |
| 2022-12-31 | CN¥5.79 Billion | +9.89% |
| 2021-12-31 | CN¥5.27 Billion | +8.45% |
| 2020-12-31 | CN¥4.86 Billion | +3.52% |
| 2019-12-31 | CN¥4.69 Billion | +12.76% |
| 2018-12-31 | CN¥4.16 Billion | +0.88% |
| 2017-12-31 | CN¥4.13 Billion | +2.67% |
| 2016-12-31 | CN¥4.02 Billion | +1.28% |
| 2015-12-31 | CN¥3.97 Billion | +14.88% |
| 2014-12-31 | CN¥3.45 Billion | +26.84% |
| 2013-12-31 | CN¥2.72 Billion | +67.57% |
| 2012-12-31 | CN¥1.62 Billion | +86.51% |
| 2011-12-31 | CN¥871.17 Million | +12.11% |
| 2010-12-31 | CN¥777.06 Million | +9.43% |
| 2009-12-31 | CN¥710.12 Million | +8.23% |
| 2008-12-31 | CN¥656.12 Million | +4.46% |
| 2007-12-31 | CN¥628.10 Million | +71.76% |
| 2006-12-31 | CN¥365.69 Million | +6.00% |
| 2005-12-31 | CN¥344.98 Million | +4.99% |
| 2004-12-31 | CN¥328.57 Million | -1.62% |
| 2003-12-31 | CN¥333.97 Million | +13.51% |
| 2002-12-31 | CN¥294.23 Million | +224.58% |
| 2001-12-31 | CN¥90.65 Million | +30.07% |
| 2000-12-31 | CN¥69.69 Million | +20.34% |
| 1999-12-31 | CN¥57.91 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Shinva Medical Instrument Co Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 54892.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥3.92 Billion | 51.65% |
| Common Stock | CN¥606.68 Million | 7.99% |
| Other Components | CN¥3.07 Billion | 40.36% |
| Total Equity | CN¥7.60 Billion | 100.00% |
Shinva Medical Instrument Co Ltd Competitors by Market Cap
The table below lists competitors of Shinva Medical Instrument Co Ltd ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Shenzhen Laibao High-Technology Co Ltd
SHE:002106
|
$845.03 Million |
|
ICICI Securities Limited
NSE:ISEC
|
$845.25 Million |
|
Kureha Corporation
F:0K1
|
$845.56 Million |
|
HÖEgh Autoliners AS
PINK:HOEGF
|
$845.58 Million |
|
Suzhou UIGreen Micro & Nano Technologies Co. Ltd. A
SHG:688661
|
$844.94 Million |
|
Gold.com, Inc.
NASDAQ:GOLD
|
$844.82 Million |
|
Five-Star Business Finance Limited
NSE:FIVESTAR
|
$844.71 Million |
|
BrightView Holdings
NYSE:BV
|
$844.55 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shinva Medical Instrument Co Ltd's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 7,318,625,200 to 7,597,127,229, a change of 278,502,029 (3.8%).
- Net income of 691,609,561 contributed positively to equity growth.
- Dividend payments of 329,034,516 reduced retained earnings.
- Share repurchases of 75,070 reduced equity.
- Other factors decreased equity by 83,997,946.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥691.61 Million | +9.1% |
| Dividends Paid | CN¥329.03 Million | -4.33% |
| Share Repurchases | CN¥75.07K | -0.0% |
| Other Changes | CN¥-84.00 Million | -1.11% |
| Total Change | CN¥- | 3.81% |
Book Value vs Market Value Analysis
This analysis compares Shinva Medical Instrument Co Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.22x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 57.55x to 1.22x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 1999-12-31 | CN¥0.27 | CN¥15.33 | x |
| 2000-12-31 | CN¥0.32 | CN¥15.33 | x |
| 2001-12-31 | CN¥0.42 | CN¥15.33 | x |
| 2002-12-31 | CN¥1.35 | CN¥15.33 | x |
| 2003-12-31 | CN¥1.47 | CN¥15.33 | x |
| 2004-12-31 | CN¥1.33 | CN¥15.33 | x |
| 2005-12-31 | CN¥1.40 | CN¥15.33 | x |
| 2006-12-31 | CN¥1.71 | CN¥15.33 | x |
| 2007-12-31 | CN¥2.11 | CN¥15.33 | x |
| 2008-12-31 | CN¥2.03 | CN¥15.33 | x |
| 2009-12-31 | CN¥2.19 | CN¥15.33 | x |
| 2010-12-31 | CN¥2.33 | CN¥15.33 | x |
| 2011-12-31 | CN¥2.65 | CN¥15.33 | x |
| 2012-12-31 | CN¥4.44 | CN¥15.33 | x |
| 2013-12-31 | CN¥6.67 | CN¥15.33 | x |
| 2014-12-31 | CN¥7.32 | CN¥15.33 | x |
| 2015-12-31 | CN¥7.95 | CN¥15.33 | x |
| 2016-12-31 | CN¥8.45 | CN¥15.33 | x |
| 2017-12-31 | CN¥8.05 | CN¥15.33 | x |
| 2018-12-31 | CN¥8.70 | CN¥15.33 | x |
| 2019-12-31 | CN¥10.28 | CN¥15.33 | x |
| 2020-12-31 | CN¥10.79 | CN¥15.33 | x |
| 2021-12-31 | CN¥12.09 | CN¥15.33 | x |
| 2022-12-31 | CN¥13.27 | CN¥15.33 | x |
| 2023-12-31 | CN¥12.31 | CN¥15.33 | x |
| 2024-12-31 | CN¥12.52 | CN¥15.33 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shinva Medical Instrument Co Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.10%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 6.90%
- • Asset Turnover: 0.65x
- • Equity Multiplier: 2.04x
- Recent ROE (9.10%) is above the historical average (8.23%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 1999 | 14.14% | 11.21% | 0.63x | 2.01x | CN¥2.40 Million |
| 2000 | 16.86% | 8.92% | 0.73x | 2.60x | CN¥4.78 Million |
| 2001 | 20.57% | 10.36% | 0.64x | 3.12x | CN¥9.58 Million |
| 2002 | 7.26% | 8.56% | 0.47x | 1.80x | CN¥-8.06 Million |
| 2003 | 7.55% | 8.74% | 0.47x | 1.82x | CN¥-7.80 Million |
| 2004 | -9.94% | -9.62% | 0.41x | 2.49x | CN¥-57.79 Million |
| 2005 | 4.95% | 3.64% | 0.54x | 2.53x | CN¥-15.42 Million |
| 2006 | 6.57% | 4.40% | 0.57x | 2.60x | CN¥-11.09 Million |
| 2007 | 3.83% | 4.24% | 0.52x | 1.73x | CN¥-36.10 Million |
| 2008 | 4.86% | 4.56% | 0.65x | 1.65x | CN¥-31.65 Million |
| 2009 | 6.35% | 4.66% | 0.86x | 1.59x | CN¥-23.68 Million |
| 2010 | 8.66% | 4.50% | 0.90x | 2.14x | CN¥-9.35 Million |
| 2011 | 13.59% | 5.09% | 1.08x | 2.47x | CN¥28.36 Million |
| 2012 | 11.05% | 5.38% | 0.90x | 2.29x | CN¥15.48 Million |
| 2013 | 9.60% | 5.52% | 0.78x | 2.23x | CN¥-9.63 Million |
| 2014 | 11.20% | 5.20% | 0.78x | 2.77x | CN¥35.02 Million |
| 2015 | 8.68% | 3.72% | 0.77x | 3.03x | CN¥-42.88 Million |
| 2016 | 1.07% | 0.41% | 0.74x | 3.50x | CN¥-290.51 Million |
| 2017 | 1.99% | 0.66% | 0.80x | 3.77x | CN¥-264.30 Million |
| 2018 | 0.69% | 0.22% | 0.83x | 3.75x | CN¥-307.74 Million |
| 2019 | 20.61% | 9.82% | 0.76x | 2.78x | CN¥443.38 Million |
| 2020 | 5.34% | 2.56% | 0.79x | 2.64x | CN¥-204.32 Million |
| 2021 | 11.32% | 5.87% | 0.82x | 2.36x | CN¥65.02 Million |
| 2022 | 9.27% | 5.39% | 0.72x | 2.40x | CN¥-39.24 Million |
| 2023 | 8.94% | 6.53% | 0.64x | 2.13x | CN¥-77.87 Million |
| 2024 | 9.10% | 6.90% | 0.65x | 2.04x | CN¥-68.10 Million |
Industry Comparison
This section compares Shinva Medical Instrument Co Ltd's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,879,733,462
- Average return on equity (ROE) among peers: 24.67%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shinva Medical Instrument Co Ltd (600587) | CN¥8.16 Billion | 14.14% | 0.85x | $845.00 Million |
| Shanghai Kehua Bio-Engineering Co Ltd (002022) | $792.82 Million | 25.77% | 0.17x | $318.98 Million |
| Jiangsu Yuyue Medical Equipment & Supply Co Ltd (002223) | $482.51 Million | 20.84% | 0.32x | $2.79 Billion |
| Double Medical Technology Inc (002901) | $224.61 Million | 43.10% | 0.32x | $404.40 Million |
| Wuhan Easy Diagnosis Biomedicine Co Ltd Class A (002932) | $1.42 Million | 98.49% | 2.27x | $281.14 Million |
| Lepu Medical Tech Beijing (300003) | $12.27 Billion | 14.01% | 0.69x | $2.71 Billion |
| INKON Life Technology Co Ltd (300143) | $1.81 Billion | -20.17% | 0.37x | $637.77 Million |
| Edan Instruments Inc (300206) | $1.26 Billion | 7.37% | 0.15x | $501.55 Million |
| Guangdong Biolight Meditech Co Ltd (300246) | $504.27 Million | 13.31% | 0.36x | $360.97 Million |
| Beijing Leadman Biochemistry Co Ltd (300289) | $1.44 Billion | 2.82% | 0.20x | $267.10 Million |
| Sinocare Inc (300298) | $17.42 Million | 41.15% | 0.68x | $952.60 Million |